Pectoral Nerves Block vs Wound Infiltration for Partial Mastectomy - a Prospective Randomized Trial.

Sponsor
Karlstad Central Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04824599
Collaborator
(none)
80
1
2
12.3
6.5

Study Details

Study Description

Brief Summary

Pectoralis nerves plane block (PECS) first described by Blanco in 2011 has become part of postoperative pain management in breast surgery, thoracic surgery and thoracic trauma. The combination of low complication risk and easiness in mastering of PECS block has made it an interesting alternative to thoracic epidural anesthesia (TEDA) and paravertebral blockade (PVB) for pain treatment after breast surgery. Several studies showed good results when PECS was compared to PVB. PECS blockade however is a procedure requiring some resources in the operating room. An alternative approach is to inject local anesthetics (LA) in the operation field by the surgeon.

The hypothesis' tested in this study is primarily: that PECS blockade is superior to LA being injected by surgeon in the operating field measured by end points such as: post-operative pain, post-operative analgesics use, post-operative nausea or vomiting (PONV) and length of stay in the post anesthesia care unit (PACU).

Condition or Disease Intervention/Treatment Phase
  • Procedure: PECS II
  • Procedure: Local anesthetic infiltration
  • Procedure: Subcutaneus local anesthetic infiltration
  • Drug: Ropivacaine
  • Device: bk medical Flex Focus 500 Ultrasound Machine
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Pectoral Interfascial Plane Block vs Wound Infiltration for Partial Mastectomy - a Prospective Randomized Trial.
Actual Study Start Date :
Feb 19, 2021
Anticipated Primary Completion Date :
Feb 1, 2022
Anticipated Study Completion Date :
Mar 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: PECS+subcutaneus local anesthetic infiltration

Preoperative ultrasound-led PECS II blockade with ropivacaine 3,75mg/ml (2mg/kg). After surgery - wound infiltration by the surgeon with ropivacaine 2mg/ml (1mg/kg).

Procedure: PECS II
Pectoral nerves block (PECS II) is performed with the help of ultrasound. Two injection are performed in two fascial planes. One between pectoralis major muscle and serratus anterior muscle. Second one between pectoralis major and minor muscles.
Other Names:
  • Pectoral nerves block
  • Procedure: Subcutaneus local anesthetic infiltration
    Ropivacaine is administered by the surgeon at the end of surgery

    Drug: Ropivacaine
    Local anesthetic ropivacaine is administered in both study arms according to the study protocol
    Other Names:
  • Local anesthetic
  • Device: bk medical Flex Focus 500 Ultrasound Machine
    Ultrasound with linear probe is performed. Using in-plane technique a correct placement of the injection needle is secured.
    Other Names:
  • High Frequency Linear 8870 probe
  • Active Comparator: Local anesthetic infiltration

    Prior to scrubbing surgeon infiltrates the thought incision area with ropivacaine 3,75/ml (1mg/kg). Perioperatively after removal of the tumor follows the deep infiltration of the wound with ropivacaine 3,75mg/ml (2mg/kg).

    Procedure: Local anesthetic infiltration
    Ropivacaine is administered by surgeon prior to scrubbing and following the removal of the tumor.

    Drug: Ropivacaine
    Local anesthetic ropivacaine is administered in both study arms according to the study protocol
    Other Names:
  • Local anesthetic
  • Outcome Measures

    Primary Outcome Measures

    1. maximal pain in PACU measured with 11 point numerical rating scale (NRS) [measured at discharge from PACU (on average 4 hours).]

      NRS scale is a validated for assessment of pain.

    Secondary Outcome Measures

    1. Maximal postoperative nausea and vomiting(PONV) in PACU measured with 11 point numerical rating scale (NRS) [measured at discharge from PACU (on average 4 hours).]

      PONV NRS similar to pain NRS is an 11 point scale used to estimate severity of postoperative nausea.

    2. Postoperative analgesic use [measured at 24 hours postoperatively.]

      Postoperative analgesic use is related to pain severity and can be a factor leading to increased length of stay in PACU.

    3. Length of stay in PACU [on average 4 hours.]

      Is an dependant of multiple factors and an important measurement that can indicate beneficial therapeutic choice.

    4. Maximal pain after discharge from PACU measured with 11 point numerical rating scale (NRS) [24 hours]

      NRS scale is a validated for assessment of pain.

    5. Maximal postoperative nausea and vomiting(PONV) after discharge from PACU measured with 11 point numerical rating scale (NRS) [24 hours]

      PONV NRS similar to pain NRS is an 11 point scale used to estimate severity of postoperative nausea.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Women scheduled for partial mastectomy (lumpectomy).
    Exclusion Criteria:
    • Scheduled cryosection

    • Axillary node dissection

    • Re-resection

    • Age under 18 or unable to give an informed concent

    • Chronic pain history

    • Allergy to local anesthetics

    • History of active drug addiction

    • Pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Central Hospital in Karlstad Karlstad Värmland Sweden 652 30

    Sponsors and Collaborators

    • Karlstad Central Hospital

    Investigators

    • Principal Investigator: Ragnar Henningsson, PhD, Örebro University, Sweden

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Patryk Eisler, Consultant in Anesthesiology and Intensive care, Karlstad Central Hospital
    ClinicalTrials.gov Identifier:
    NCT04824599
    Other Study ID Numbers:
    • LIVFOU-930411
    First Posted:
    Apr 1, 2021
    Last Update Posted:
    Apr 1, 2021
    Last Verified:
    Mar 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Patryk Eisler, Consultant in Anesthesiology and Intensive care, Karlstad Central Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 1, 2021